The drug for partial and generalized tonic-clonic seizures is:

Questions 213

ATI RN

ATI RN Test Bank

Effects of Pharmacological Treatments on Clients Across a Lifespan Questions

Question 1 of 5

The drug for partial and generalized tonic-clonic seizures is:

Correct Answer: D

Rationale: In the treatment of partial and generalized tonic-clonic seizures, the correct drug is "All of the above" (Option D), which includes Carbamazepine, Valproate, and Phenytoin. Carbamazepine is commonly used for partial seizures, Valproate is effective for both types of seizures, and Phenytoin is often used for generalized tonic-clonic seizures. Choosing "All of the above" ensures that the patient receives the appropriate treatment based on the type of seizure. Option A (Carbamazepine) is incorrect because it is primarily used for partial seizures and not generalized tonic-clonic seizures. Option B (Valproate) is incorrect as it is not specific to generalized tonic-clonic seizures. Option C (Phenytoin) is incorrect for partial seizures but is effective for generalized tonic-clonic seizures. In an educational context, understanding the specific pharmacological treatments for different types of seizures is crucial for healthcare professionals working with clients across the lifespan. Proper medication selection is essential for managing seizure disorders effectively and minimizing adverse effects. This knowledge ensures optimal patient care and safety in various clinical settings.

Question 2 of 5

Valproate is very effective against:

Correct Answer: D

Rationale: Valproate, a medication commonly used in the treatment of epilepsy, is indeed very effective against various types of seizures. The correct answer is D) All of the above because valproate is effective in treating absence seizures, myoclonic seizures, and generalized tonic-clonic seizures. For absence seizures (option A), valproate is a first-line treatment due to its ability to effectively control the abnormal electrical activity in the brain responsible for these types of seizures. Regarding myoclonic seizures (option B), valproate has also shown efficacy in reducing the frequency and severity of these sudden, brief muscle jerks characteristic of this seizure type. In the case of generalized tonic-clonic seizures (option C), valproate is considered a broad-spectrum antiepileptic drug that can help prevent the occurrence of these seizures, which involve both tonic (muscle stiffness) and clonic (muscle jerking) phases. Educationally, understanding the specific efficacy of valproate in treating different types of seizures is crucial for healthcare professionals working with clients across the lifespan who may present with various forms of epilepsy. By knowing which seizures valproate can effectively target, healthcare providers can make informed decisions when selecting pharmacological treatments to optimize patient outcomes and quality of life.

Question 3 of 5

Which of the following neurotransmitters is involved in Parkinson′s disease?

Correct Answer: C

Rationale: Dopamine is the key neurotransmitter involved in Parkinson’s disease, with its deficiency due to nigrostriatal neuron loss causing motor symptoms. While acetylcholine and glutamate are part of basal ganglia function, dopamine’s reduction is the hallmark of the disease, making 'Dopamine' the correct answer.

Question 4 of 5

Which of the following statements is correct for levodopa?

Correct Answer: D

Rationale: In this case, the correct answer is D) All of the above. Levodopa is a common medication used in the treatment of Parkinson's disease, and understanding its effects across a client's lifespan is crucial for healthcare professionals. Explanation of why D is correct: - Tolerance to both beneficial and adverse effects of levodopa develops gradually: Over time, patients may require higher doses of levodopa to achieve the same therapeutic effects due to tolerance development. - Levodopa is most effective in the first 2-5 years of treatment: Patients typically experience the greatest symptomatic relief in the early years of levodopa therapy, after which the response may become less consistent. - After 5 years of therapy, patients have dose-related dyskinesias, inadequate response, or toxicity: Prolonged use of levodopa can lead to motor complications such as dyskinesias, fluctuations in response, or medication-related side effects. Explanation of why A, B, and C are incorrect: - Option A is incorrect because tolerance to both beneficial and adverse effects of levodopa does develop gradually. - Option B is incorrect because while levodopa is effective in the first few years of treatment, its efficacy may decrease over time. - Option C is incorrect as it presents a partial truth; after 5 years of therapy, patients can experience a range of issues, not just a single outcome. Educational context: Understanding the long-term effects of pharmacological treatments on clients across their lifespan is a critical aspect of providing quality care. Healthcare professionals need to be aware of how medications like levodopa can impact patients over time to effectively manage their conditions and optimize treatment outcomes. By grasping the nuances of medication effects, professionals can make informed decisions and adjustments to medication regimens to ensure the best possible care for their clients.

Question 5 of 5

Which of the following antiparkinsonian drugs is an antiviral agent used in the prophylaxis of influenza A2?

Correct Answer: D

Rationale: In this scenario, the correct answer is D) Amantadine. Amantadine is an antiviral agent that is used not only in the treatment of influenza A2 but also as an antiparkinsonian drug. It works by blocking the replication of the influenza virus. Option A) Selegiline is a selective irreversible MAO-B inhibitor used in the treatment of Parkinson's disease by increasing dopamine levels in the brain but is not an antiviral agent. Option B) Sinemet is a combination of carbidopa and levodopa used to treat symptoms of Parkinson's disease by increasing dopamine levels and is not an antiviral agent. Option C) Pergolide is a dopamine receptor agonist used in the treatment of Parkinson's disease but is not an antiviral agent. Understanding the pharmacological treatments for various conditions across the lifespan is crucial for healthcare professionals. Knowledge of specific drugs, their indications, mechanisms of action, and potential side effects is essential for effective patient care. In this case, understanding that Amantadine is not only used as an antiparkinsonian drug but also as an antiviral agent highlights its versatility in clinical practice. This knowledge enables healthcare providers to make informed decisions when managing patients with these conditions.

Access More Questions!

ATI RN Basic


$89/ 30 days

ATI RN Premium


$150/ 90 days

Similar Questions